Cargando…
Сytotoxic effect of CAR-T cells against modified MCF-7 breast cancer cell line
The most often diagnosed and fatal malignancy in women is breast cancer. The International Agency for Research on Cancer (IARC) estimates that there are 2.26 million new cases of cancer in 2020. Adoptive cell therapy using T cells with chimeric antigen receptor shows potential for the treatment of s...
Autores principales: | Valiullina, Aigul Kh., Zmievskaya, Ekaterina A., Ganeeva, Irina A., Zhuravleva, Margarita N., Garanina, Ekaterina E., Rizvanov, Albert A., Petukhov, Alexey V., Bulatov, Emil R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Shiraz University
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10599594/ https://www.ncbi.nlm.nih.gov/pubmed/37886737 http://dx.doi.org/10.22099/mbrc.2023.47125.1820 |
Ejemplares similares
-
Evaluation of CAR-T Cells’ Cytotoxicity against Modified Solid Tumor Cell Lines
por: Valiullina, Aigul Kh., et al.
Publicado: (2023) -
Application of CAR-T Cell Therapy beyond Oncology: Autoimmune Diseases and Viral Infections
por: Zmievskaya, Ekaterina, et al.
Publicado: (2021) -
Adoptive Immunotherapy beyond CAR T-Cells
por: Titov, Aleksei, et al.
Publicado: (2021) -
Knowns and Unknowns about CAR-T Cell Dysfunction
por: Titov, Aleksei, et al.
Publicado: (2022) -
Advancing CAR T-Cell Therapy for Solid Tumors: Lessons Learned from Lymphoma Treatment
por: Titov, Aleksei, et al.
Publicado: (2020)